Jonathan Couchman - Net Worth and Insider Trading

Jonathan Couchman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonathan Couchman owns 4 companies in total, including Enzon Pharmaceuticals Inc (ENZN) , Myrexis Inc (MYRX) , and Xstelos Holdings Inc (XTLS) among others .

Click here to see the complete history of Jonathan Couchman’s form 4 insider trades.

Insider Ownership Summary of Jonathan Couchman

Ticker	Comapny	Transaction Date	Type of Owner
ENZN	Enzon Pharmaceuticals Inc	2018-04-04	10 percent owner & other: See Footnote 1
MYRX	Myrexis Inc	2013-01-22	director & Chairman & President and CEO
XTLS	Xstelos Holdings Inc	2012-04-23	director & 10 percent owner & President and CEO
		2010-01-03	director

Jonathan Couchman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jonathan Couchman Ownership Network

Ownership Network List of Jonathan Couchman

No Data

Ownership Network Relation of Jonathan Couchman

Jonathan Couchman Owned Company Details

What does Enzon Pharmaceuticals Inc do?

Who are the key executives at Enzon Pharmaceuticals Inc?

Jonathan Couchman is the 10 percent owner & other: See Footnote 1 of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .

Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enzon Pharmaceuticals Inc Insider Transactions

No Available Data

What does Myrexis Inc do?

Who are the key executives at Myrexis Inc?

Jonathan Couchman is the director & Chairman & President and CEO of Myrexis Inc. Other key executives at Myrexis Inc include 10 percent owner Xstelos Corp. , 10 percent owner First Eagle Investment Management, Llc , and director & Chief Operating Officer David W Gryska .

Myrexis Inc (MYRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Myrexis Inc (MYRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myrexis Inc (MYRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Myrexis Inc (MYRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Myrexis Inc Insider Transactions

No Available Data

What does Xstelos Holdings Inc do?

Who are the key executives at Xstelos Holdings Inc?

Jonathan Couchman is the director & 10 percent owner & President and CEO of Xstelos Holdings Inc.

Xstelos Holdings Inc (XTLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xstelos Holdings Inc (XTLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xstelos Holdings Inc (XTLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xstelos Holdings Inc (XTLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xstelos Holdings Inc Insider Transactions

No Available Data

What does Pernix Therapeutics Holdings Inc do?

Who are the key executives at Pernix Therapeutics Holdings Inc?

Jonathan Couchman is the director of Pernix Therapeutics Holdings Inc. Other key executives at Pernix Therapeutics Holdings Inc include SVP & CBO & Principal Fin Off Angus W. Smith , VP of Fin & PAO & Controller Glenn Whaley , and director & President and CFO Graham G Miao .

Pernix Therapeutics Holdings Inc (PTXTQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pernix Therapeutics Holdings Inc (PTXTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pernix Therapeutics Holdings Inc (PTXTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pernix Therapeutics Holdings Inc (PTXTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pernix Therapeutics Holdings Inc Insider Transactions

No Available Data

Jonathan Couchman Mailing Address

Above is the net worth, insider trading, and ownership report for Jonathan Couchman. You might contact Jonathan Couchman via mailing address: 630 Fifth Avenue, Suite 2260, New York Ny 10020.

Discussions on Jonathan Couchman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.